Literature DB >> 2579476

Lack of covalent binding of peroxisome proliferators nafenopin and Wy-14 643 to DNA in vivo and in vitro.

S K Goel, N D Lalwani, W E Fahl, J K Reddy.   

Abstract

[3H][2-methyl-2-p-(1,2,3,4-tetrahydro-naphthyl)phenoxy] propionic acid (nafenopin), a hepatocarcinogenic peroxisome proliferator, when administered p.o. to normal intact and partially hepatectomized male F344 rats did not show any significant binding to DNA and RNA, but bound to proteins. The in vitro incubation of [3H]nafenopin and [3H]4-chloro-[6-(2,3-xylidino)pyrimidinylthio]acetic acid (Wy-14643), another peroxisome proliferator, with hepatic microsomes and calf thymus DNA also showed no significant binding of these chemicals to DNA.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2579476     DOI: 10.1016/0378-4274(85)90137-7

Source DB:  PubMed          Journal:  Toxicol Lett        ISSN: 0378-4274            Impact factor:   4.372


  3 in total

1.  Time-dependence and differential induction of rat and guinea pig peroxisomal beta-oxidation, palmitoyl-CoA hydrolase, cytosolic and microsomal epoxide hydrolase after treatment with hypolipidemic drugs.

Authors:  F Oesch; R Hartmann; C Timms; M Strolin-Benedetti; P Dostert; W Wörner; L Schladt
Journal:  J Cancer Res Clin Oncol       Date:  1988       Impact factor: 4.553

2.  Induction of peroxisome proliferation and hepatic tumours in C57BL/6N mice by ciprofibrate, a hypolipidaemic compound.

Authors:  M S Rao; R S Dwivedi; V Subbarao; J K Reddy
Journal:  Br J Cancer       Date:  1988-07       Impact factor: 7.640

3.  Comparison of hepatic peroxisome proliferative effect and its implication for hepatocarcinogenicity of phthalate esters, di(2-ethylhexyl) phthalate, and di(2-ethylhexyl) adipate with a hypolipidemic drug.

Authors:  J K Reddy; M K Reddy; M I Usman; N D Lalwani; M S Rao
Journal:  Environ Health Perspect       Date:  1986-03       Impact factor: 9.031

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.